Gene · 3777
Papers1,851
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
141 to 160 of 1,851
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Genomic and GEO data integration identifies PDGFB as a potential therapeutic target for sepsis. | Sci Rep | 2025 | 40221544 | PubTator, text mining | PubMed |
| Mechanistic insights into the potentiation and toxicity mitigation of myocardial infarction treatment with salvianolate and ticagrelor. | Phytomedicine | 2025 | 40209643 | PubTator, text mining | PubMed |
| Exploration of the multiomics-based mechanisms of Gancao Nourishing-Yin decoction in regulating mitochondrial metabolic genes CYB5R3 and PICK1 to influence glioma progression. | Discov Oncol | 2025 | 40198489 | PubTator, text mining | PubMed |
| Mediators of the causal associations between protein ratios and ischemic stroke: a two-step Mendelian randomization study. | Neurol Res | 2025 | 40181221 | PubTator, text mining | PubMed |
| Rational design, synthesis, and evaluation of novel polypharmacological compounds targeting NaV1.5, KV1.5, and K2P channels for atrial fibrillation. | J Biol Chem | 2025 | 40054693 | PubTator, text mining | PubMed |
| Evaluating the Cardiometabolic Efficacy and Safety of Lipoprotein Lipase Pathway Targets in Combination With Approved Lipid-Lowering Targets: A Drug Target Mendelian Randomization Study. | Circ Genom Precis Med | 2025 | 40052268 | PubTator, text mining | PubMed |
| Multi-omics study on autophagic dysfunction molecular network in the pathogenesis of rheumatoid arthritis. | J Transl Med | 2025 | 40045304 | PubTator, text mining | PubMed |
Consistent Safety and Efficacy of Sotatercept for Pulmonary Arterial Hypertension in BMPR2 Mutation Carriers and Noncarriers: A Planned Analysis of a Phase II, Double-Blind, Placebo-controlled Clinical Trial (PULSAR). | Am J Respir Crit Care Med | 2025 | 40035659 | PubTator, text mining | PubMed |
| Evaluation of Adefovir PBPK Model to Assess Biomarker-Informed OAT1 Drug-Drug Interaction and Effect of Chronic Kidney Disease. | CPT Pharmacometrics Syst Pharmacol | 2025 | 40033714 | PubTator, text mining | PubMed |
| SFRP2 mediates Epstein-Barr virus and bladder cancer risk: a Mendelian randomization study and colocalization analysis. | Sci Rep | 2025 | 40016549 | PubTator, text mining | PubMed |
| Discovery of ONO-2920632 (VU6011887): A Highly Selective and CNS Penetrant TREK-2 (TWIK-Related K+ Channel 2) Preferring Activator In Vivo Tool Compound. | ACS Chem Neurosci | 2025 | 39981749 | PubTator, text mining | PubMed |
| Unveiling the role of sex in the metabolism of indoxyl sulfate and apixaban. | Sci Rep | 2025 | 39972038 | PubTator, text mining | PubMed |
| Identifying potential drug targets for seborrheic keratosis through druggable genome-wide Mendelian randomization and colocalization analysis. | Arch Dermatol Res | 2025 | 39918628 | PubTator, text mining | PubMed |
| 17th European College of Equine Internal Medicine (ECEIM) Congress Copenhagen, Denmark 14-16 November 2024. | J Vet Intern Med | 2025 | 39836076 | PubTator, text mining | PubMed |
| Investigating causal relationships of blood and urine biomarkers with urological cancer risks: a mendelian randomization study and colocalization analyses. | J Cancer | 2025 | 39781351 | PubTator, text mining | PubMed |
| Genetic associations of plasma metabolites with immune cells in hyperthyroidism revealed by Mendelian randomization and GWAS-sc-eQTLs xQTLbiolinks analysis. | Sci Rep | 2025 | 39779799 | PubTator, text mining | PubMed |
| Structures of TASK-1 and TASK-3 K2P channels provide insight into their gating and dysfunction in disease. | Structure | 2025 | 39637865 | Swiss-Prot, curated | PubMed |
| Human Genetic Evidence to Inform Clinical Development of IL-6 Signaling Inhibition for Abdominal Aortic Aneurysm. | Arterioscler Thromb Vasc Biol | 2025 | 39633572 | PubTator, text mining | PubMed |
| Deciphering the genetic underpinnings of neuroticism: A Mendelian randomization study of druggable gene targets. | J Affect Disord | 2025 | 39491682 | PubTator, text mining | PubMed |
| GWAShug: a comprehensive platform for decoding the shared genetic basis between complex traits based on summary statistics. | Nucleic Acids Res | 2025 | 39380491 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/3777/papers?page=8